Bausch Health Cos Price to Free Cash Flow Ratio 2010-2023 | BHC
Historical price to free cash flow ratio values for Bausch Health Cos (BHC) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Bausch Health Cos Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2024-04-26 |
8.71 |
|
1.46 |
| 2023-12-31 |
8.02 |
$5.97 |
1.34 |
| 2023-09-30 |
8.22 |
$1.54 |
5.33 |
| 2023-06-30 |
8.00 |
$1.08 |
7.42 |
| 2022-12-31 |
6.28 |
$-2.61 |
0.00 |
| 2022-09-30 |
6.89 |
$1.06 |
6.47 |
| 2022-06-30 |
8.36 |
$4.98 |
1.68 |
| 2022-03-31 |
22.85 |
$7.90 |
2.89 |
| 2021-12-31 |
27.61 |
$9.18 |
3.01 |
| 2023-03-31 |
8.10 |
$5.46 |
1.48 |
| 2021-09-30 |
27.85 |
$6.12 |
4.55 |
| 2021-06-30 |
29.32 |
$3.43 |
8.56 |
| 2021-03-31 |
31.74 |
$2.81 |
11.29 |
| 2020-12-31 |
20.80 |
$2.34 |
8.90 |
| 2020-09-30 |
15.54 |
$1.83 |
8.48 |
| 2020-06-30 |
18.29 |
$2.66 |
6.87 |
| 2020-03-31 |
15.50 |
$3.11 |
4.99 |
| 2019-12-31 |
29.92 |
$3.62 |
8.26 |
| 2019-09-30 |
21.85 |
$3.91 |
5.58 |
| 2019-06-30 |
25.22 |
$5.84 |
4.32 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$3.150B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
